Remington G - Search Results

1

Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome.

Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Cohn T, et al. Among authors: remington g. Can J Psychiatry. 2004 Nov;49(11):753-60. doi: 10.1177/070674370404901106. Can J Psychiatry. 2004. PMID: 15633853

2

Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.

Remington GJ, Voineskos G, Pollock B, Reed K, Coulter K. Remington GJ, et al. Am J Psychiatry. 1990 Sep;147(9):1231-3. doi: 10.1176/ajp.147.9.1231. Am J Psychiatry. 1990. PMID: 1974747

3

The remitting atypical psychoses: clinical and nosologic considerations.

Remington G, Menuck M, Schmidt P, Legault S. Remington G, et al. Can J Psychiatry. 1990 Feb;35(1):36-40. doi: 10.1177/070674379003500106. Can J Psychiatry. 1990. PMID: 2317732

4

Pharmacotherapy of schizophrenia.

Remington G. Remington G. Can J Psychiatry. 1989 Apr;34(3):211-20. doi: 10.1177/070674378903400310. Can J Psychiatry. 1989. PMID: 2566367 Review.

5

The question of lithium/neuroleptic toxicity.

Jeffries J, Remington G, Wilkins J. Jeffries J, et al. Among authors: remington g. Can J Psychiatry. 1984 Nov;29(7):601-4. doi: 10.1177/070674378402900711. Can J Psychiatry. 1984. PMID: 6150756

6

Clinical considerations in the use of risperidone.

Remington GJ. Remington GJ. Can J Psychiatry. 1993 Sep;38 Suppl 3:S96-100. Can J Psychiatry. 1993. PMID: 7504575 Review.

7

Novel neuroleptics in schizophrenia: theory and clinical relevance.

Remington GJ. Remington GJ. Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S43-5. Can J Psychiatry. 1994. PMID: 7533050 No abstract available.

8

The long-term treatment of schizophrenia.

Remington GJ. Remington GJ. Can J Psychiatry. 1995 Apr;40(3 Suppl 1):S3-4. Can J Psychiatry. 1995. PMID: 7627926 No abstract available.

9

Depot neuroleptic therapy: clinical considerations.

Remington GJ, Adams ME. Remington GJ, et al. Can J Psychiatry. 1995 Apr;40(3 Suppl 1):S5-11. Can J Psychiatry. 1995. PMID: 7627927 Review.

10

Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms.

Bezchlibnyk-Butler KZ, Remington GJ. Bezchlibnyk-Butler KZ, et al. Among authors: remington gj. Can J Psychiatry. 1994 Mar;39(2):74-84. doi: 10.1177/070674379403900203. Can J Psychiatry. 1994. PMID: 7908605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results